Johnson & Johnson’s $21.3 billion acquisition of Synthes may drive its orthopedic device rivals Zimmer and Stryker to make their own deals, according to a report by Bloomberg.
Zimmer and Stryker, which mostly build knee and hip devices, may be under pressure to buy smaller orthopedic companies in faster-growing parts of the industry, said David Turkaly, an analyst at Susquehanna Financial Group. Likely targets include ArthroCare, BioMimetic Therapeutics, Wright Medical Group and Mako Surgical, he said.
"What clearly happens is J&J becomes No. 1 in all of ortho," Mr. Turkaly said. "The Strykers and Zimmers of the world are probably now a good distance behind the animal that J&J is in those markets."
Read the Bloomberg report on orthopedics device companies.
Related Articles on the Orthopedic and Spine Market:
Johnson & Johnson to Acquire Synthes for $21.3B
Millennium Research Group: Orthopedic Extremities Market to Generate $4.6B by 2015
6 Predictions on Device Market Growth in the Next Five Years
Zimmer and Stryker, which mostly build knee and hip devices, may be under pressure to buy smaller orthopedic companies in faster-growing parts of the industry, said David Turkaly, an analyst at Susquehanna Financial Group. Likely targets include ArthroCare, BioMimetic Therapeutics, Wright Medical Group and Mako Surgical, he said.
"What clearly happens is J&J becomes No. 1 in all of ortho," Mr. Turkaly said. "The Strykers and Zimmers of the world are probably now a good distance behind the animal that J&J is in those markets."
Read the Bloomberg report on orthopedics device companies.
Related Articles on the Orthopedic and Spine Market:
Johnson & Johnson to Acquire Synthes for $21.3B
Millennium Research Group: Orthopedic Extremities Market to Generate $4.6B by 2015
6 Predictions on Device Market Growth in the Next Five Years